Demographics and outcomes of patients before and after project implementation—from the original study7
| Pre-intervention (n=100) | Post-intervention (n=102) | P value | |
| Mean age (SD), years | 62 (10.6) | 59 (10.5) | 0.038 |
| Mean BMI (SD), kg/m2 | 32 (9.5) | 32 (9.2) | 0.8 |
| Charlson Comorbidity Index | |||
| 0 | 14 (14%) | 16 (16%) | 0.54 |
| 1 | 19 (19%) | 27 (26%) | |
| 2 | 33 (33%) | 30 (29%) | |
| 3 or higher | 34 (34%) | 29 (28%) | |
| Pre-operative diagnosis, n (%) | |||
| Uterine cancer | 85 (85%) | 72 (71%) | 0.015* |
| Ovarian cancer | 1 (1%) | 10 (10%) | |
| Cervical cancer | 3 (3%) | 3 (3%) | |
| Ovarian neoplasm | 11 (11%) | 15 (15%) | |
| Other | 0 | 2 (2%) | |
| MIS approach, n (%) | |||
| Laparoscopic | 63 (63%) | 81 (79%) | 0.015* |
| Robotic | 37 (37%) | 21 (21%) | |
| Conversion, n (%) | 8 (8%) | 1 (1%) | 0.018* |
| Final FIGO stage, n (%) | |||
| Benign/borderline | 1 (1%) | 19 (19%) | <0.001* |
| 1 | 80 (80%) | 64 (63%) | |
| 2 | 15 (15%) | 11 (11%) | |
| 3 | 3 (3%) | 7 (7%) | |
| 4 | 1 (1%) | 1 (1%) | |
| Same day discharge, n (%) | 29 (29%) | 77 (75%) | <0.001* |
| Overnight stay, n (%) | 71 (71%) | 25 (25%) | |
| 1 night | 56 | 23 | |
| 2 nights or longer | 15 | 2 | |
| Unplanned clinic visits <30 days, n (%) | 6 (6%) | 8 (8%) | 1 |
| ER visits <30 days, n (%) | 8 (8%) | 8 (8%) | 1 |
| Readmissions <30 days, n (%) | 2 (2%) | 2 (2%) | 1 |
| Re-operation <30 days, n (%) | 3 (3%) | 1 (1%) | 0.37 |
BMI, body mass index; ER, emergency room; FIGO, International Federation of Obstetrics and Gynecology; MIS, minimally invasive surgery; m2/kg, meter squared by kilogram; n, number; sd, standard deviation.